Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Invest ; 118(12): 4025-35, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19033671

RESUMO

Normal airways homeostatically regulate the volume of airway surface liquid (ASL) through both cAMP- and Ca2+-dependent regulation of ion and water transport. In cystic fibrosis (CF), a genetic defect causes a lack of cAMP-regulated CFTR activity, leading to diminished Cl- and water secretion from airway epithelial cells and subsequent mucus plugging, which serves as the focus for infections. Females with CF exhibit reduced survival compared with males with CF, although the mechanisms underlying this sex-related disadvantage are unknown. Despite the lack of CFTR, CF airways retain a limited capability to regulate ASL volume, as breathing-induced ATP release activates salvage purinergic pathways that raise intracellular Ca2+ concentration to stimulate an alternate pathway to Cl- secretion. We hypothesized that estrogen might affect this pathway by reducing the ability of airway epithelia to respond appropriately to nucleotides. We found that uridine triphosphate-mediated (UTP-mediated) Cl- secretion was reduced during the periovulatory estrogen maxima in both women with CF and normal, healthy women. Estrogen also inhibited Ca2+ signaling and ASL volume homeostasis in non-CF and CF airway epithelia by attenuating Ca2+ influx. This inhibition of Ca2+ signaling was prevented and even potentiated by estrogen antagonists such as tamoxifen, suggesting that antiestrogens may be beneficial in the treatment of CF lung disease because they increase Cl- secretion in the airways.


Assuntos
Cálcio/metabolismo , Fibrose Cística/metabolismo , Estradiol/metabolismo , Antagonistas de Estrogênios/farmacologia , Homeostase/efeitos dos fármacos , Tamoxifeno/farmacologia , Água/metabolismo , Trifosfato de Adenosina/metabolismo , Adulto , Células Cultivadas , Cloretos/metabolismo , AMP Cíclico/metabolismo , Fibrose Cística/tratamento farmacológico , Fibrose Cística/mortalidade , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Antagonistas de Estrogênios/uso terapêutico , Feminino , Humanos , Transporte de Íons/efeitos dos fármacos , Masculino , Mucosa Respiratória , Fatores Sexuais , Tamoxifeno/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...